• Psyched Wellness Ltd. (PSYC) has signed an agreement with KGK Science to study the anti-inflammatory nature of AME-1
  • KGK Science specializes in nutraceutical product testing and development and is leading the pre-clinical trials for Psyched
  • This new agreement will further advance the preliminary findings indicating an anti-inflammatory property
  • When gut health is damaged, it can lead to inflammation thus promoting a chronic condition of the gut lining
  • The aim of the study is to explore the anti-inflammatory properties of AME-1 extract
  • Psyched Wellness Ltd. (PSYC) is in the grey and is trading at C$0.30 at 1:31 pm ET

Psyched Wellness Ltd. (PSYC) has signed an agreement with its CRO partner, KGK Science to further study the anti-inflammatory nature of AME-1.

KGK Science specializes in nutraceutical product testing and development and is leading the pre-clinical trials for Psyched.

This new agreement will advance the preliminary findings indicating an anti-inflammatory property of the AME-1 extract.

This study will be the first to further explore the anti-inflammatory nature of the AME-1 extract from the Amanita Muscaria mushroom with a particular focus on gut health.

When gut health is damaged, it can lead to inflammation thus promoting a chronic condition of the gut lining and impairment of barrier function of the digestive tract.

The aim of the study is to explore the anti-inflammatory properties of AME-1 extract and demonstrate activities that may enhance digestive barrier function and immunity.

This is significant as gut health and immunity promotion are substantial for health and wellness.

“This is a key first step in the health and wellness studies of AME-1, which lay the groundwork for future preclinical research,” said Brian Tancowny, scientific advisor to Psyched Wellness.

Psyched Wellness is a Canadian-based health supplements company dedicated to the distribution of mushroom-derived products and associated consumer packaged goods.

Its objective is to create premium mushroom-derived products that have the potential to become a leading North American brand in the emerging functional food category. 

Psyched Wellness Ltd. (PSYC) is in the grey and is trading at C$0.30 at 1:31 pm ET.

More From The Market Online

Canadian biotech stock investigates potential weight loss drugs

FSD Pharma Inc. (CSE:HUGE) is expanding its pipeline into metabolic and related disorders including weight loss and liver health.
The Market Online Video

Emerging opportunity in a growing, high-value dermatological market

Kane Biotech (TSXV:KNE) engages in the development and commercialization of products that prevent and remove microbial biofilms.